Table 2.
Time segment and prognosis of AMI inpatients.
| 2019 (n = 256) | 2020 (n = 207) | p | |
|---|---|---|---|
| S2FMC time (minutes) | 309 (84.25–1267.50) | 251 (80–1080) | 0.552 |
| Conservative therapy (N) | 50 | 34 | 0.389 |
| Thrombolytic therapy (N) | 1 | 2 | 0.443 |
| Invasive treatment (N) | 205 | 171 | 0.488 |
| LVEF | 62 (52.5–67.5) | 62 (54.5–67.0) | 0.826 |
| In-hospital mortality (%) | 3.9 | 3.4 | 0.765 |
| STEMI in-hospital mortality (%) | 3.9 | 3.3 | 0.822 |
| NSTEMI in-hospital mortality (%) | 3.9 | 3.6 | 0.941 |
| Hospitalization length (days) | 7 (5–9) | 7 (5–8.25) | 0.410 |
| STEMI hospitalization length (days) | 7 (5.25–9) | 6 (5–8) | 0.122 |
| NSTEMI hospitalization length (days) | 7 (5–9) | 7 (5–9) | 0.903 |
| Patients admitted within 12 hours of onset (%) | 73.4 | 68.1 | 0.335 |
AMI: acute myocardial infarction; S2FMC: symptoms to the first medical contact; STEMI: ST-elevation myocardial infarction; NSTEMI: non-ST-elevation myocardial infarction; LVEF: left ventricular ejection fraction; N: number.